nu

Moderna shares soar following positive skin cancer vaccine news

Moderna shares soar following positive skin cancer vaccine news

Moderna shares surged nearly 88 percent on Wall Street following the announcement of positive clinical trial results for a new skin cancer vaccine. The study indicates that the vaccine effectively reduces the risk of cancer recurrence or spread.

Related articles